These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. Baczko K; Liebert UG; Billeter M; Cattaneo R; Budka H; ter Meulen V J Virol; 1986 Aug; 59(2):472-8. PubMed ID: 3735490 [TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of structural protein genes of the Yamagata-1 strain of defective subacute sclerosing panencephalitis virus. IV. Nucleotide sequence of the fusion gene. Komase K; Haga T; Yoshikawa Y; Sato TA; Yamanouchi K Virus Genes; 1990 Jul; 4(2):173-81. PubMed ID: 1698327 [TBL] [Abstract][Full Text] [Related]
31. Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. Cattaneo R; Rose JK J Virol; 1993 Mar; 67(3):1493-502. PubMed ID: 8437226 [TBL] [Abstract][Full Text] [Related]
32. Measles viral load may reflect SSPE disease progression. Kühne Simmonds M; Brown DW; Jin L Virol J; 2006 Jun; 3():49. PubMed ID: 16790043 [TBL] [Abstract][Full Text] [Related]
33. Hemadsorption expressed by cloned H genes from subacute sclerosing panencephalitis (SSPE) viruses and their possible progenitor measles viruses isolated in Osaka, Japan. Furukawa K; Ayata M; Kimura M; Seto T; Matsunaga I; Murata R; Yamano T; Ogura H Microbiol Immunol; 2001; 45(1):59-68. PubMed ID: 11270608 [TBL] [Abstract][Full Text] [Related]
34. Suppression of viral RNA polymerase activity is necessary for persistent infection during the transformation of measles virus into SSPE virus. Sakamoto K; Konami M; Kameda S; Satoh Y; Wakimoto H; Kitagawa Y; Gotoh B; Jiang DP; Hotta H; Itoh M PLoS Pathog; 2023 Jul; 19(7):e1011528. PubMed ID: 37494386 [TBL] [Abstract][Full Text] [Related]
35. Alterations and diversity in the cytoplasmic tail of the fusion protein of subacute sclerosing panencephalitis virus strains isolated in Osaka, Japan. Ning X; Ayata M; Kimura M; Komase K; Furukawa K; Seto T; Ito N; Shingai M; Matsunaga I; Yamano T; Ogura H Virus Res; 2002 Jun; 86(1-2):123-31. PubMed ID: 12076836 [TBL] [Abstract][Full Text] [Related]
36. Defective translation of measles virus matrix protein in a subacute sclerosing panencephalitis cell line. Carter MJ; Willcocks MM; ter Meulen V Nature; 1983 Sep 8-14; 305(5930):153-5. PubMed ID: 6888557 [TBL] [Abstract][Full Text] [Related]
37. A role for dual viral hits in causation of subacute sclerosing panencephalitis. Oldstone MB; Dales S; Tishon A; Lewicki H; Martin L J Exp Med; 2005 Nov; 202(9):1185-90. PubMed ID: 16260490 [TBL] [Abstract][Full Text] [Related]
38. Measles virus matrix protein gene expression in a subacute sclerosing panencephalitis patient brain and virus isolate demonstrated by cDNA hybridization and immunocytochemistry. Brown HR; Goller NL; Thormar H; Rudelli R; Tourtellotte WW; Shapshak P; Boostanfar R; Wisniewski HM Acta Neuropathol; 1987; 75(2):123-30. PubMed ID: 3324622 [TBL] [Abstract][Full Text] [Related]
39. The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different. Hirano A; Wang AH; Gombart AF; Wong TC Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8745-9. PubMed ID: 1528889 [TBL] [Abstract][Full Text] [Related]
40. Generalized and localized biased hypermutation affecting the matrix gene of a measles virus strain that causes subacute sclerosing panencephalitis. Wong TC; Ayata M; Hirano A; Yoshikawa Y; Tsuruoka H; Yamanouchi K J Virol; 1989 Dec; 63(12):5464-8. PubMed ID: 2585612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]